4.8 Article

The Nutritional Management of Hepatic Encephalopathy in Patients With Cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus

Journal

HEPATOLOGY
Volume 58, Issue 1, Pages 325-336

Publisher

WILEY
DOI: 10.1002/hep.26370

Keywords

-

Ask authors/readers for more resources

Nitrogen metabolism plays a major role in the development of hepatic encephalopathy (HE) in patients with cirrhosis. Modulation of this relationship is key to the management of HE, but is not the only nutritional issue that needs to be addressed. The assessment of nutritional status in patients with cirrhosis is problematic. In addition, there are significant sex-related differences in body composition and in the characteristics of tissue loss, which limit the usefulness of techniques based on measures of muscle mass and function in women. Techniques that combine subjective and objective variables provide reasonably accurate information and are recommended. Energy and nitrogen requirements in patients with HE are unlikely to differ substantially from those recommended in patients with cirrhosis per se viz. 35-45 kcal/g and 1.2-1.5g/kg protein daily. Small meals evenly distributed throughout the day and a late-night snack of complex carbohydrates will help minimize protein utilization. Compliance is, however, likely to be a problem. Diets rich in vegetables and dairy protein may be beneficial and are therefore recommended, but tolerance varies considerably in relation to the nature of the staple diet. Branched chain amino acid supplements may be of value in the occasional patient intolerant of dietary protein. Increasing dietary fiber may be of value, but the utility of probiotics is, as yet, unclear. Short-term multivitamin supplementation should be considered in patients admitted with decompensated cirrhosis. Hyponatremia may worsen HE; it should be prevented as far as possible and should always be corrected slowly. Conclusion: Effective management of these patients requires an integrated multidimensional approach. However, further research is needed to fill the gaps in the current evidence base to optimize the nutritional management of patients with cirrhosis and HE.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level

Carlos Perez-Monter, Alejandro Alvarez-Arce, Natalia Nuno-Lambarri, Ivonne Escalona-Nandez, Eva Juarez-Hernandez, Norberto C. Chavez-Tapia, Misael Uribe, Varenka J. Barbero-Becerra

Summary: Supplementing inulin in a classic obesity and fatty liver model mice can effectively prevent hepatic steatosis and reshape the composition of intestinal microbiota.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Gastroenterology & Hepatology

Laparoscopic cholecystectomy: Histopathological analysis of metabolic associated fatty liver disease and fibrosis

Itzayana Rodriguez-Antonio, Guillermo N. Lopez-Sanchez, Victor A. Reyes-Gomez, Ericka H. Contreras-Flores, Fernanda Farias-Garcia, Mariana Espejel-Deloiza, Marco A. Duran-Padilla, Fredy Chable-Montero, Misael Uribe, Norberto C. Chavez-Tapia, Eduardo E. Montalvo-Jave, Natalia Nuno-Lambarri

Summary: The study aimed to determine the severity of MAFLD and associated risk factors in patients with cholelithiasis. Among the 80 patients studied, 58.8% had MAFLD, but no substantial correlation was found between biochemical parameters and the histopathological analysis of MAFLD and fibrosis.

ANNALS OF HEPATOLOGY (2022)

Article Biology

Toward a Molecular Approach to Chronotype Assessment

Alberto Biscontin, Lisa Zarantonello, Antonella Russo, Rodolfo Costa, Sara Montagnese

Summary: The study aimed to develop a Polygenic Score-based model for molecular chronotype assessment and identified 83 variants predictive of chronotype with an estimated validity of approximately 80%.

JOURNAL OF BIOLOGICAL RHYTHMS (2022)

Article Multidisciplinary Sciences

Incremental levels of diagnostic information incentivize health-seeking in non-alcoholic fatty liver: a randomized clinical trial

Norberto C. Chavez-Tapia, Tonatiuh Barrientos-Gutierrez, Leticia Torres-Ibarra, Beatriz Sanchez-Jimenez, Eva Juarez-Hernandez, Martha Ramos-Ostos, Luis F. Alva-Lopez, Misael Uribe

Summary: This study aims to evaluate the effect of providing different levels of diagnostic information on medical care-seeking in adults newly diagnosed with NAFLD. The results showed that patients who received more information sought specialized medical care more frequently, which may help to increase patients' health-seeking behavior.

SCIENTIFIC REPORTS (2022)

Editorial Material Gastroenterology & Hepatology

Clues to decipher the origin of severe acute hepatitis in children: a new enigma during the COVID-19 pandemic

Misael Uribe, Arturo Panduro, Gisela DuPont, Nora A. Fierro

ANNALS OF HEPATOLOGY (2022)

Letter Gastroenterology & Hepatology

Author's reply: Clinical association and detection of spontaneous portosystemic shunts in cirrhosis

Sahaj Rati, Piero Amodio

DIGESTIVE AND LIVER DISEASE (2022)

Article Medicine, General & Internal

Hepatic encephalopathy

Dieter Haeussinger, Radha K. Dhiman, Vicente Felipo, Boris Gorg, Rajiv Jalan, Gerald Kircheis, Manuela Merli, Sara Montagnese, Manuel Romero-Gomez, Alfons Schnitzler, Simon D. Taylor-Robinson, Hendrik Vilstrup

Summary: Hepatic encephalopathy is a neuropsychiatric syndrome that occurs in patients with liver disease. It affects the quality of life of patients and is the most serious complication of decompensated liver cirrhosis. Ammonia and inflammation play key roles in the development of hepatic encephalopathy, leading to cerebral edema, oxidative/nitrosative stress, inflammation, and disturbances in brain networks. Lactulose and rifaximin are currently the main medical treatments.

NATURE REVIEWS DISEASE PRIMERS (2022)

Article Gastroenterology & Hepatology

Hyperammonaemia disrupts daily rhythms reversibly by elevating glutamate in the central circadian pacemaker

Daniel Granados-Fuentes, Kevin Cho, Gary J. Patti, Rodolfo Costa, Erik D. Herzog, Sara Montagnese

Summary: Hyperammonaemia affects circadian regulation of rest-activity behavior by increasing extracellular glutamate levels in the suprachiasmatic nuclei.

LIVER INTERNATIONAL (2023)

Review Oncology

Keeping an eye on circadian time in clinical research and medicine

Elizabeth B. Klerman, Allison Brager, Mary A. Carskadon, Christopher M. Depner, Russell Foster, Namni Goel, Mary Harrington, Paul M. Holloway, Melissa P. Knauert, Monique K. LeBourgeois, Jonathan Lipton, Martha Merrow, Sara Montagnese, Mingming Ning, David Ray, Frank A. J. L. Scheer, Steven A. Shea, Debra J. Skene, Claudia Spies, Bart Staels, Marie-Pierre St-Onge, Steffen Tiedt, Phyllis C. Zee, Helen J. Burgess

Summary: The manuscript provides guidance on measuring metrics of endogenous circadian rhythms in humans and advocates for the inclusion of circadian rhythms assessments in health and disease studies. It describes protocols and analyses commonly used for studying human daily rhythms and recommends definitions and examples of circadian terminology.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Editorial Material Gastroenterology & Hepatology

Ammonia - an enduring foe - What evaluating whole body ammonia metabolism can teach us about cirrhosis and therapies treating hepatic encephalopathy

Debbie L. Shawcross, Dominique Thabut, Piero Amodio

JOURNAL OF HEPATOLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

Minimal Hepatic Encephalopathy Is Associated With an Increased Risk of Overt Hepatic Encephalopathy and Poorer Prognosis - A Multicenter Study

Simon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, Stefania Gioia, Elise Jonasson Nielsen, Sven Danneberg, Anna S. Lok, Philippe Sultanik, Peter Robert Galle, Joachim Labenz, Dominique Thabut, Jens Uwe Marquardt, Patricia P. Bloom, Mette Munk Lauridsen, Sara Montagnese, Silvia Nardelli, Christian Labenz

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

Working Memory in Patients With Varying Degree of Hepatic Encephalopathy Before and After a Course of Rifaximin: An EEG-fNIRS Study

Lisa Zarantonello, Chiara Mangini, Davide Erminelli, Silvano Fasolato, Paolo Angeli, Piero Amodio, Sara Montagnese

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Medicine, General & Internal

Animal naming test is a simple and valid tool for detecting covert hepatic encephalopathy and predicting outcomes in Chinese-speaking regions: a preliminary study

Chien-Hao Huang, Tung-Yang Yu, Wei-En Johnny Tseng, Yu-Tung Huang, Shang-Hung Chang, Sen-Yung Hsieh, Rong-Nan Chien, Piero Amodio

Summary: This study aimed to investigate the potential of the animal naming test (ANT(1) and simplified ANT(1) (s-ANT(1))) for assessing covert hepatic encephalopathy (CHE) in Chinese-speaking regions, specifically Taiwan. The study found that ANT(1) and s-ANT(1) showed diagnostic and prognostic value for CHE.

ANNALS OF MEDICINE (2023)

Article Biochemistry & Molecular Biology

Working Memory in Patients with Varying Degree of Hepatic Encephalopathy (HE): A Pilot EEG-fNIRS Study

Lisa Zarantonello, Chiara Mangini, Davide Erminelli, Silvano Fasolato, Paolo Angeli, Piero Amodio, Sara Montagnese

Summary: It is known that patients with covert hepatic encephalopathy (CHE) exhibit working memory abnormalities, but there is no study comparing patients with cirrhosis with/without CHE and controls with both electrophysiological and hemodynamic data collected at the same time. This study showed that the presence of cirrhosis had more effects on working memory than CHE at baseline. Treatment with rifaximin was more beneficial to patients without CHE, suggesting greater room for improvement in this complex task.

NEUROCHEMICAL RESEARCH (2023)

Article Medicine, General & Internal

Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival

Simon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, Stefania Gioia, Elise Jonasson Nielsen, Sven Danneberg, Anna S. Lok, Philippe Sultanik, Peter Robert Galle, Joachim Labenz, Dominique Thabut, Jens Uwe Marquardt, Patricia P. Bloom, Mette Munk Lauridsen, Sara Montagnese, Silvia Nardelli, Christian Labenz

Summary: This large multicenter study demonstrates that screening for minimal hepatic encephalopathy (MHE) is a useful tool for predicting the development of overt hepatic encephalopathy (OHE) and poorer survival.

JOURNAL OF INTERNAL MEDICINE (2023)

No Data Available